{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T23:47:04Z","timestamp":1775000824457,"version":"3.50.1"},"reference-count":38,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,2,18]],"date-time":"2022-02-18T00:00:00Z","timestamp":1645142400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>To determine the frequency and severity of complications associated with the continuous intra-arterial infusion of nimodipine (CIANI) as a new treatment of delayed cerebral ischemia (DCI) after aneurysmal subarachnoid hemorrhage (SAH).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Patients from two centers (<jats:italic>n<\/jats:italic> = 718) treated for SAH between 2008 and 2016 were included. Demographic and SAH-related parameters were evaluated, and also the frequency of adverse events (AEs) and complications including their severity (mild, moderate, and severe). Clinical outcome was analyzed using Glasgow Outcome Scale (GOS). The unfavorable outcome was defined as GOS 1 to 3, and favorable outcome as GOS 4 to 5. The Short-Form 36 (SF-36) health-related quality-of-life (QoL) questionnaire served as a QoL measurement.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Of 718 patients, 65 (9%) were treated by CIANI and had a higher clinical or imaging grade of bleeding severity. Clinical deterioration while on treatment happened more often in patients who were treated with CIANI than in others. In patients with CIANI, 67% had AEs and\/or complications during the treatment. Nimodipine-associated hypotension was seen in 8% (mild). Catheter-associated thrombus occurred in 9% (moderate). New intracerebral hemorrhage was found in 14% (moderate). A total of 6% treated by CIANI died during the treatment period (severe). More than one-third (39%) of patients of CIANI reached at least moderate disability, and 23% showed good recovery. Patients who received CIANI showed reduced QoL, but differences in mental and general health, and also pain were minimal.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Patients who received CIANI had higher rates of AEs and complications. However, this does not exclude the possibility that the use of CIANI might be helpful in patients with severe and therapy-refractory CV and DCI. Controlled and randomized studies would be helpful to clarify this question but they are methodologically and ethically challenging.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fneur.2021.812898","type":"journal-article","created":{"date-parts":[[2022,2,18]],"date-time":"2022-02-18T08:50:26Z","timestamp":1645174226000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["Adverse Events and Complications in Continuous Intra-arterial Nimodipine Infusion Therapy After Aneurysmal Subarachnoid Hemorrhage"],"prefix":"10.3389","volume":"12","author":[{"given":"Thomas","family":"Kapapa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralph","family":"K\u00f6nig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Mayer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Braun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernd","family":"Schmitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silwia","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Schick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian Rainer","family":"Wirtz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrej","family":"Pala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,2,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1161\/STROKEAHA.110.589275","article-title":"Definition of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage as an outcome event in clinical trials and observational studies: proposal of a multidisciplinary research group","volume":"41","author":"Vergouwen","year":"2010","journal-title":"Stroke."},{"key":"B2","doi-asserted-by":"publisher","first-page":"106064","DOI":"10.1016\/j.jstrokecerebrovasdis.2021.106064","article-title":"Delayed cerebral ischemia after subarachnoid hemorrhage","volume":"30","author":"Ikram","year":"2021","journal-title":"J Stroke Cerebrovasc Dis."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1111\/aas.13412","article-title":"Delayed cerebral ischaemia in patients with aneurysmal subarachnoid haemorrhage: functional outcome and long-term mortality","volume":"63","author":"Olsen","year":"2019","journal-title":"Acta Anaesthesiol Scand."},{"key":"B4","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.wneu.2011.02.030","article-title":"Vasospasm after aneurysmal subarachnoid hemorrhage: review of randomized controlled trials and meta-analyses in the literature","volume":"76","author":"Velat","year":"2011","journal-title":"World Neurosurg."},{"key":"B5","doi-asserted-by":"publisher","first-page":"e021845","DOI":"10.1161\/JAHA.121.021845","article-title":"Pathophysiology of delayed cerebral ischemia after subarachnoid hemorrhage: a review","volume":"10","author":"Dodd","year":"2021","journal-title":"J Am Heart Assoc."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.3174\/ajnr.A1005","article-title":"Intra-arterial nimodipine for severe cerebral vasospasm after aneurysmal subarachnoid hemorrhage: influence on clinical course and cerebral perfusion","volume":"29","author":"Hanggi","year":"2008","journal-title":"AJNR Am J Neuroradiol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s12028-017-0428-1","article-title":"Side effects of long-term continuous intra-arterial nimodipine infusion in patients with severe refractory cerebral vasospasm after subarachnoid hemorrhage","volume":"28","author":"Kieninger","year":"2018","journal-title":"Neurocrit Care."},{"key":"B8","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1007\/s00701-015-2597-z","article-title":"Continuous intra-arterial nimodipine infusion in patients with severe refractory cerebral vasospasm after aneurysmal subarachnoid hemorrhage: a feasibility study and outcome results","volume":"157","author":"Bele","year":"2015","journal-title":"Acta Neurochir."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1227\/NEU.0b013e31820edd46","article-title":"Continuous local intra-arterial nimodipine administration in severe symptomatic vasospasm after subarachnoid hemorrhage","volume":"68","author":"Musahl","year":"2011","journal-title":"Neurosurgery"},{"key":"B10","doi-asserted-by":"publisher","first-page":"970741","DOI":"10.1155\/2014\/970741","article-title":"Continuous selective intra-arterial application of nimodipine in refractory cerebral vasospasm due to aneurysmal subarachnoid hemorrhage","volume":"2014","author":"Ott","year":"2014","journal-title":"Biomed Res Int."},{"key":"B11","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/s10143-018-0986-5","article-title":"The evolution of invasive cerebral vasospasm treatment in patients with spontaneous subarachnoid hemorrhage and delayed cerebral ischemia-continuous selective intracarotid nimodipine therapy in awake patients without sedation","volume":"42","author":"Pala","year":"2019","journal-title":"Neurosurg Rev."},{"key":"B12","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.wneu.2017.02.014","article-title":"Effect of intra-arterial and intravenous nimodipine therapy of cerebral vasospasm after subarachnoid hemorrhage on cerebrovascular reactivity and oxygenation","volume":"101","author":"Hockel","year":"2017","journal-title":"World Neurosurg."},{"key":"B13","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1007\/s12028-009-9317-6","article-title":"Continuous selective intraarterial infusion of nimodipine for therapy of refractory cerebral vasospasm","volume":"12","author":"Wolf","year":"2010","journal-title":"Neurocrit Care."},{"key":"B14","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.wneu.2016.12.110","article-title":"Clinical course and monitoring parameters after continuous interventional intra-arterial treatment in patients with refractory cerebral vasospasm","volume":"100","author":"Von Der Brelie","year":"2017","journal-title":"World Neurosurg."},{"key":"B15","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1159\/000346087","article-title":"European Stroke Organization guidelines for the management of intracranial aneurysms and subarachnoid haemorrhage","volume":"35","author":"Steiner","year":"2013","journal-title":"Cerebrovasc Dis."},{"key":"B16","doi-asserted-by":"publisher","first-page":"CD009176","DOI":"10.1002\/14651858.CD009176.pub2","article-title":"Daily sedation interruption versus no daily sedation interruption for critically ill adult patients requiring invasive mechanical ventilation","volume":"2014","author":"Burry","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"B17","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/S0140-6736(09)62072-9","article-title":"A protocol of no sedation for critically ill patients receiving mechanical ventilation: a randomised trial","volume":"375","author":"Strom","year":"2010","journal-title":"Lancet."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.3171\/2015.4.JNS15428","article-title":"Vasospasm on transcranial Doppler is predictive of delayed cerebral ischemia in aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis","volume":"124","author":"Kumar","year":"2016","journal-title":"J Neurosurg."},{"key":"B19","doi-asserted-by":"publisher","first-page":"985","DOI":"10.3171\/jns.1988.68.6.0985","article-title":"Report of world federation of neurological surgeons committee on a universal subarachnoid hemorrhage grading scale","volume":"68","author":"Drake","year":"1988","journal-title":"J Neurosurg."},{"key":"B20","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3171\/jns.1968.28.1.0014","article-title":"Surgical risk as related to time of intervention in the repair of intracranial aneurysms","volume":"28","author":"Hunt","year":"1968","journal-title":"J Neurosurg."},{"key":"B21","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1227\/01.NEU.0000218821.34014.1B","article-title":"Prediction of symptomatic vasospasm after subarachnoid hemorrhage: the modified fisher scale","volume":"59","author":"Frontera","year":"2006","journal-title":"Neurosurgery"},{"key":"B22","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1093\/qjmed\/hcu145","article-title":"Adverse events in healthcare: learning from mistakes","volume":"108","author":"Rafter","year":"2015"},{"key":"B23","volume-title":"Lange Critical Care","author":"Oropello","year":"2016"},{"key":"B24","first-page":"XVII","article-title":"Assessment of health related quality of life with the SF-36 Health Survey","volume":"35","author":"Bullinger","year":"1996","journal-title":"Rehabilitation (Stuttg)."},{"key":"B25","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.wneu.2012.10.009","article-title":"Health-related quality of life after spontaneous subarachnoid hemorrhage measured in a recent patient population","volume":"79","author":"Tjahjadi","year":"2013","journal-title":"World Neurosurg."},{"key":"B26","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.wneu.2012.09.011","article-title":"Cerebral vasospasm and health-related quality of life after subarachnoid hemorrhage","volume":"80","author":"Tjahjadi","year":"2013","journal-title":"World Neurosurg."},{"key":"B27","doi-asserted-by":"publisher","first-page":"e519","DOI":"10.1161\/STROKEAHA.110.581975","article-title":"Cognitive and functional outcome after aneurysmal subarachnoid hemorrhage","volume":"41","author":"Al-Khindi","year":"2010","journal-title":"Stroke."},{"key":"B28","doi-asserted-by":"publisher","first-page":"603","DOI":"10.3171\/2013.1.JNS122368","article-title":"Subarachnoid hemorrhage and outcome","volume":"119","author":"Macdonald","year":"2013","journal-title":"J Neurosurg."},{"key":"B29","first-page":"1067","article-title":"Intra-arterial nimodipine for the treatment of symptomatic cerebral vasospasm after aneurysmal subarachnoid hemorrhage: preliminary results","volume":"25","author":"Biondi","year":"2004","journal-title":"AJNR Am J Neuroradiol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"407","DOI":"10.3109\/02688697.2016.1161172","article-title":"Is intra arterial nimodipine really beneficial in vasospasm following aneurysmal subarachnoid haemorrhage?","volume":"30","author":"Goel","year":"2016","journal-title":"Br J Neurosurg."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.3171\/2020.3.JNS20375","article-title":"Invasive neuromonitoring with an extended definition of delayed cerebral ischemia is associated with improved outcome after poor-grade subarachnoid hemorrhage","volume":"134","author":"Veldeman","year":"2020","journal-title":"J Neurosurg."},{"key":"B32","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1007\/s12028-020-01169-x","article-title":"Treatment of delayed cerebral ischemia in good-grade subarachnoid hemorrhage: any role for invasive neuromonitoring?","volume":"35","author":"Veldeman","year":"2021","journal-title":"Neurocrit Care."},{"key":"B33","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1159\/000487325","article-title":"Risk factors and clinical impact of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage: analysis from the china national stroke registry","volume":"50","author":"Duan","year":"2018","journal-title":"Neuroepidemiology."},{"key":"B34","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1186\/s13054-016-1447-6","article-title":"Management of delayed cerebral ischemia after subarachnoid hemorrhage","volume":"20","author":"Francoeur","year":"2016","journal-title":"Crit Care."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.3171\/2018.11.JNS182891","article-title":"The influence of nimodipine and vasopressors on outcome in patients with delayed cerebral ischemia after spontaneous subarachnoid hemorrhage","volume":"132","author":"Pala","year":"2019","journal-title":"J Neurosurg."},{"key":"B36","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1097\/WNP.0000000000000273","article-title":"The pathophysiology of delayed cerebral ischemia","volume":"33","author":"Foreman","year":"2016","journal-title":"J Clin Neurophysiol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1177\/1971400915626429","article-title":"Intra-arterial nimodipine for cerebral vasospasm after subarachnoid haemorrhage: influence on clinical course and predictors of clinical outcome","volume":"29","author":"Bashir","year":"2016","journal-title":"Neuroradiol J."},{"key":"B38","doi-asserted-by":"publisher","first-page":"157","DOI":"10.7461\/jcen.2015.17.3.157","article-title":"Clinical variables correlated with numbers of intra-arterial nimodipine infusion in patients with medically refractory cerebral vasospasm","volume":"17","author":"Kim","year":"2015","journal-title":"J Cerebrovasc Endovasc Neurosurg."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2021.812898\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,18]],"date-time":"2022-02-18T08:50:33Z","timestamp":1645174233000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2021.812898\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,18]]},"references-count":38,"alternative-id":["10.3389\/fneur.2021.812898"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2021.812898","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,18]]},"article-number":"812898"}}